BIODESIGN OTOLOGIC REPAIR GRAFT G44839 ENT-OTO-0.6-0.9

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2018-01-11 for BIODESIGN OTOLOGIC REPAIR GRAFT G44839 ENT-OTO-0.6-0.9 manufactured by Cook Biotech.

Event Text Entries

[97013549] Additional mfg narrative-notes date of event not provided by the complainant, 510(k) k161000 previously k150594. A review of the device lot history records indicated the device was manufactured to specifications. The documented non-conformance would not have contributed to the reported feedback. A total of ten (10) devices was produced from the lot. A review of the cbi complaint database did not reveal any additional complaints associated with the reported lot number. A review of the ifu revealed that perforation and recurrence are amongst the list of potential complications that "are possible with the use of surgical device materials in otologic procedures. " a direct root cause, to the reported perforation persistence and increase in size, is inconclusive. Factors that could contribute to the reported outcome include: patient? S overall health, lack of viable tissue in area being treated, inadequate blood supply to the repair, graft too small for defect, user technique, and patient post-operative care of the treated area and overall post-op patient activities. The reported worsening of the patient? S hearing is a secondary effect of the perforation persistence and/or increase in size.
Patient Sequence No: 1, Text Type: N, H10


[97013550] On (b)(6) 2017, dr. (b)(6) implanted an ent-oto-0. 6x0. 9 for repair of a tympanic membrane perforation. This was a clean and dry procedure. No infection was present at the time of device placement. The perforation was small (under 10%) and centrally located. The device was hydrated and placed in an underlay fashion. Gelfoam was placed in the middle ear and an unspecified ointment was used on the external ear. The tympanic perforation persisted and increased in size. No infection was present, the device degraded / did not remodel, but it was not retrieved. The patient's hearing reportedly worsened from the pre-op state of hearing. The surgeon reported the patient will need another operation.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1835959-2018-00001
MDR Report Key7183410
Report SourceCOMPANY REPRESENTATIVE
Date Received2018-01-11
Date of Report2018-01-11
Date Mfgr Received2017-12-15
Device Manufacturer Date2017-06-27
Date Added to Maude2018-01-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. PERRY GUINN
Manufacturer Street1425 INNOVATION PLACE
Manufacturer CityWEST LAFAYETTE IN 47906
Manufacturer CountryUS
Manufacturer Postal47906
Manufacturer Phone7654973355
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIODESIGN OTOLOGIC REPAIR GRAFT
Generic NameOTOLOGIC REPAIR GRAFT
Product CodeKHJ
Date Received2018-01-11
Model NumberG44839
Catalog NumberENT-OTO-0.6-0.9
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerCOOK BIOTECH
Manufacturer Address1425 INNOVATION PLACE WEST LAFAYETTE IN 47906 US 47906


Patients

Patient NumberTreatmentOutcomeDate
10 2018-01-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.